| المؤلفون: |
Langerbeins P; University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, German CLL Study Group, Cologne, Germany., Robrecht S; University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, German CLL Study Group, Cologne, Germany., Nieper P; University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, German CLL Study Group, Cologne, Germany., Cramer P; University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, German CLL Study Group, Cologne, Germany., Fürstenau M; University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, German CLL Study Group, Cologne, Germany., Al-Sawaf O; University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, German CLL Study Group, Cologne, Germany., Fink A; University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, German CLL Study Group, Cologne, Germany., Kreuzer K; University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, German CLL Study Group, Cologne, Germany., Vehling-Kaiser U; Practice for Oncology and Hematology, Landshut, Germany., Tausch E; Ulm University, Division of CLL, Department of Internal Medicine III, Ulm, Germany., Schneider C; Ulm University, Division of CLL, Department of Internal Medicine III, Ulm, Germany., Müller L; Practice for Oncology and Hematology, Leer, Germany., Schlag R; Practice for Oncology and Hematology, Würzburg, Germany., Freier W; Practice for Oncology and Hematology, Hildesheim, Germany., Gaska T; Brüderkrankenhaus St. Josef, Department of Hematology and Oncology, Paderborn, Germany., Balser C; Practice for Oncology and Hematology, Marburg, Germany., Reiser M; Practice for Oncology and Hematology, Cologne, Germany., Stauch M; Practice for Oncology and Hematology, Kronach, Germany., Zahn M; Practice for Oncology and Hematology, Goslar, Germany., Dörfel S; Onkozentrum Dresden Freiberg, Dresden, Germany., Eckart MJ; Practice for Oncology and Hematology, Erlangen, Germany., Staib P; St Antonius Hospital Eschweiler, Eschweiler, Germany., Behlendorf T; Practice for Oncology and Hematology, Halle, Germany., Hensel M; Practice for Oncology and Hematology, Mannheim, Germany., Hebarth H; Stauferklinikum Schwäbisch Gmünd, Department for Internal Medicine, Hematology and Oncology, Mutlangen, Germany., Klaproth H; Practice for Oncology and Hematology, Neunkirchen, Germany., Block A; University Hospital Hamburg - Eppendorf, Department II, Medical Clinic and Polyclinic, Oncology, Hematology and Bone Marrow Transplantation, Hamburg, Germany., Liersch R; Practice for Oncology and Hematology, Münster, Germany., Hauch U; Practice for Oncology and Hematology, Erfurt, Germany., Heinrich B; Practice for Oncology and Hematology, Augsburg, Germany., Wendtner C; Klinikum Schwabing, Department of Hematology, Oncology, Immunology, Palliative Care, Infectious Diseases and Tropical Medicine, Munich, Germany., Fischer K; University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, German CLL Study Group, Cologne, Germany., Stilgenbauer S; Ulm University, Division of CLL, Department of Internal Medicine III, Ulm, Germany., Eichhorst B; University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, German CLL Study Group, Cologne, Germany., Hallek M; University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, German CLL Study Group, Cologne, Germany. |
Full Text Finder